“Why they say this mRNA platform is more nimble is because you’re only giving the blueprints ... we can make the mRNA quickly, so when we [figure out] which strain of virus is now going to be dominant, they can go change that quickly in the manufacturing process and get that out,”

Cynthia Leifer · said date not stated · reported 2026-08-11

Leifer explained why the mRNA platform is considered more nimble in adjusting to new dominant virus strains.